North America

PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases

Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...

 November 07, 2025 | News

Nona Biosciences Expands Partnership with Umoja Biopharma to Advance Next-Generation In Vivo CAR-T Therapies

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™),  announced an evaluation and licen...

 November 06, 2025 | News

iLeukon’s mRNA IL-2 Therapy ILKN421H Achieves 80% Response Rate in Lung Cancer Trial

ILKN421H is a novel lipid nanoparticle (LNP)-formulated mRNA encoding a non-alpha HSA–IL-2v fusion protein and dominantly expressed in lymphoid org...

 November 05, 2025 | News

AVEO and HiberCell Partner to Develop First-in-Human PERK Inhibitor for Kidney Cancer

  First-in-Human PERK inhibitor (HC-5404) to be developed in combination with AVEO's FOTIVDA® (tivozanib) for RCC – –  AVEO...

 November 05, 2025 | News

Bio-Techne and Nucleai Demonstrate Predictive Power of Spatial Biomarkers in Melanoma

Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomar...

 November 05, 2025 | News

Phenomix’s MyPhenome Test Validates GLP-1 Response Prediction Across 88,000 Patients

Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in ...

 November 05, 2025 | Report

MilliporeSigma and Promega Forge Strategic Partnership to Advance Next-Generation Drug Discovery

Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies. Aims to improve researcher acces...

 November 04, 2025 | News

ICHORtec Expands Collaboration with Johns Hopkins to Advance Quantum-Driven Precision in CRISPR Gene Editing

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newb...

 October 30, 2025 | News

Suvoda Launches Unified Patient App to Simplify Clinical Trial Participation and Boost Retention

 Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions t...

 October 30, 2025 | News

Thermo Fisher to Acquire Clario for US$8.9 Billion to Expand Digital and AI-Driven Clinical Trial Capabilities

Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margin ...

 October 30, 2025 | News

SimplyTest Launches Saliva-Based Oral HPV Test to Transform Early Detection of Oropharyngeal Cancers

SimplyTest® has launched a groundbreaking saliva-based test to detect high-risk strains of oral human papillomavirus (HPV), a major cause of oropharyng...

 October 29, 2025 | News

Swiss Rockets Secures Global License for MGI CoolMPS Sequencing Platform to Advance Multi-Omics Innovation

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced  that they entered into a exclusive license agreement with MGI Tech and Complete Genomi...

 October 29, 2025 | News

Curia Invests $4 Million to Upgrade API Aseptic Suites in Spain to Meet New EU GMP Annex 1 Standards

Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investmen...

 October 28, 2025 | News

Terumo Receives FDA Clearance for OPUSWAVE Dual Sensor Imaging System Combining OFDI and IVUS Technologies

OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs ...

 October 27, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close